MNG Expands Their Scientific Leadership
ATLANTA, GA, November 13, 2017 /24-7PressRelease/ — MNG Laboratories, a globally recognized clinical diagnostic leader specializing in neurogenetic and complex biochemical testing, is pleased to announce the appointment of five distinguished members of the genetic community to its Scientific Advisory Board. All members have recognized leadership roles in the genetic/diagnostic testing field and will assist MNG Laboratories by providing critical scientific support to MNG’s existing and future diagnostics business.
“We are pleased to have the support of such an accomplished and universally respected group of scientists and physician scientists. They represent the level of integrity and scientific standards that MNG is striving for in all its products and dealings with our customers. Each board member brings a unique area of expertise to the ever-expanding menu of molecular and biochemical tests that MNG has to offer. I look forward to working with them as we grow our technical capabilities and bring innovative, ever more comprehensive tests to the marketplace.” – Dr. Peter L. Nagy, Chief Medical Officer, MNG.
“Thank you for the honor to serve on MNG Laboratories’ Scientific Advisory Board. I am very impressed with the breadth and quality of your work, and feel you are on the right track with your new projects.” – Uta Francke, M.D.
MNG’s Scientific Advisory Board consists of:
Uta Francke M.D.
Department of Genetics
Stanford University School of Medicine
Val C. Sheffield, M.D., Ph.D.
Professor of Pediatrics and Ophthalmology
Director, Division of Medical Genetics
Roy J. Carver Chair in Molecular Genetics
Investigator, Wynn Institute for Vision Research
University of Iowa Carver College of Medicine
Iowa City, IA
Kevin P. Campbell, Ph.D
Howard Hughes Medical Institute
Molecular Physiology and Biophysics
University of Iowa, Carver College of Medicine
Iowa City, IA
Howard J. Worman, M.D.
Professor of Medicine and Pathology and Cell Biology
College of Physicians and Surgeons
New York, NY
Benjamin Tycko, M.D., Ph.D.
Department of Biomedical Research
Division of Genetics & Epigenetics
Hackensack University Medical Center
About MNG Laboratories
MNG Laboratories is an internationally recognized clinical diagnostic leader specializing in neurogenetic and complex biochemical testing. We are committed to a patient-centered testing menu, high-quality diagnostics, and first-in-class reporting driven by our Genome MaNaGer analysis pipeline. Our Neurogenetic Answers reporting process helps us stay at the forefront of the evolving genetics field. Our team-based approach to data interpretation ensures we provide actionable results on the variants that cause or are likely to cause disease. Our comprehensive approach to diagnostics is accompanied by a team of customer support and scientific personnel available to answer your questions regarding our process, technology, and reports. With over 15 years of neurogenetic experience, and powered by a culture of discovery and advancement, MNG Laboratories delivers results that make a difference for patients and their families.
More information about MNG Laboratories can be found at mnglabs.com.
Peter L. Nagy, MD PhD
For the original version of this press release, please visit 24-7PressRelease.com here